Beam Therapeutics (BEAM) Common Equity (2019 - 2026)
Beam Therapeutics' Common Equity came in at $952.67 million for Q3 2026, down 2.1% from $972.66 million a year earlier and down 10.8% from the prior quarter.
Powered by 
Analysis
Beam Therapeutics (BEAM) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Beam Therapeutics' Common Equity was $1.24 billion, up 68.8% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 38.2% (FY2020 to FY2025).
- Going back by year, Common Equity was $733.55 million in FY2024 (-25.2%), $981.33 million in FY2023 (+33.8%), $733.47 million in FY2022 (-11.3%) and $826.74 million in FY2021 (+236.7%).
- The Q3 2026 figure represents the lowest quarterly Common Equity since Q4 2024.
- Year-over-year, Common Equity increased in six of the last eight quarters, with growth averaging 14.5%.
- The fastest year-over-year change in Common Equity over five years came in Q4 2021 (growth of 236.7%), and the weakest in Q4 2024 (a decline of 25.2%).
- Business Quant data shows BEAM's Common Equity at $1.07 billion (Q2 2026), $1.16 billion (Q1 2026) and $1.24 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Beam Therapeutics | 2.73 Bn | -1.93 Bn | - | 952.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 952.67 Mn |
| Jun 30, 2026 | 1.07 Bn |
| Mar 31, 2026 | 1.16 Bn |
| Dec 31, 2025 | 1.24 Bn |
| Sep 30, 2025 | 966.00 Mn |
| Jun 30, 2025 | 1.05 Bn |
| Mar 31, 2025 | 1.13 Bn |
| Dec 31, 2024 | 733.55 Mn |
| Sep 30, 2024 | 791.32 Mn |
| Jun 30, 2024 | 854.09 Mn |
| Mar 31, 2024 | 913.49 Mn |
| Dec 31, 2023 | 981.33 Mn |
| Sep 30, 2023 | 778.94 Mn |
| Jun 30, 2023 | 811.64 Mn |
| Mar 31, 2023 | 761.51 Mn |
| Dec 31, 2022 | 733.47 Mn |
| Sep 30, 2022 | 714.48 Mn |
| Jun 30, 2022 | 800.16 Mn |
| Mar 31, 2022 | 829.07 Mn |
| Dec 31, 2021 | 826.74 Mn |
API Access
Beam Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BEAM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();